Roche Holding’s (RHHBY) Equal Weight Rating Reiterated at Morgan Stanley
A number of other research firms have also weighed in on RHHBY. Zacks Investment Research lowered Roche Holding from a strong-buy rating to a hold rating in a research report on Tuesday, May 9th. BNP Paribas reissued a neutral rating on shares of Roche Holding in a report on Tuesday, June 20th. Cowen and Company raised Roche Holding from a market perform rating to an outperform rating and increased their target price for the company from $25.25 to $33.37 in a report on Wednesday, April 5th. HSBC Holdings plc lowered Roche Holding from a hold rating to a reduce rating in a report on Friday, April 7th. Finally, Societe Generale lowered Roche Holding from a buy rating to a hold rating in a report on Friday, June 30th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and five have assigned a buy rating to the company. The stock presently has a consensus rating of Hold and an average price target of $37.00.
Shares of Roche Holding (NASDAQ:RHHBY) opened at 31.29 on Wednesday. The firm’s 50-day moving average price is $32.02 and its 200 day moving average price is $31.81. The company has a market cap of $213.55 billion and a PE ratio of 21.15. Roche Holding has a 12 month low of $25.25 and a 12 month high of $36.82.
COPYRIGHT VIOLATION WARNING: This story was published by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The correct version of this story can be viewed at https://www.watchlistnews.com/roche-holdings-rhhby-equal-weight-rating-reiterated-at-morgan-stanley/1462254.html.
Institutional investors have recently bought and sold shares of the stock. Mechanics Bank Trust Department bought a new position in Roche Holding during the first quarter valued at about $217,000. Ferguson Wellman Capital Management Inc. increased its position in Roche Holding by 13.6% in the first quarter. Ferguson Wellman Capital Management Inc. now owns 297,504 shares of the company’s stock valued at $9,529,000 after buying an additional 35,617 shares in the last quarter. Rothschild Investment Corp IL increased its position in Roche Holding by 0.7% in the first quarter. Rothschild Investment Corp IL now owns 16,142 shares of the company’s stock valued at $517,000 after buying an additional 113 shares in the last quarter. Patten & Patten Inc. TN increased its position in Roche Holding by 9.6% in the first quarter. Patten & Patten Inc. TN now owns 225,823 shares of the company’s stock valued at $7,233,000 after buying an additional 19,765 shares in the last quarter. Finally, Jolley Asset Management LLC increased its position in Roche Holding by 6.0% in the first quarter. Jolley Asset Management LLC now owns 45,845 shares of the company’s stock valued at $1,468,000 after buying an additional 2,580 shares in the last quarter.
About Roche Holding
Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.
Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with Analyst Ratings Network's FREE daily email newsletter.